Identification of novel mycobacterial antigens presented by MHC-I and -II by immunopeptidomics for vaccines against tuberculosis

Identification of novel mycobacterial antigens presented by MHC-I and -II by immunopeptidomics for vaccines against tuberculosis

Bibliografiset tiedot
Päätekijät:	Bettencourt, P, Mueller, J, Nicastri, A, Madhavan, M, Fotso, C, Cantillon, D, Charles, P, Wittenberg, R, Bull, N, Pinpathomrat, N, Waddell, S, Stylianou, E, Hill, A, Ternette, N, McShane, H
Aineistotyyppi:	Conference item
Kieli:	English
Julkaistu:	Wiley 2019

Samankaltaisia teoksia

Identification of antigens presented by MHC for vaccines against tuberculosis
Tekijä: Bettencourt, P, et al.
Julkaistu: (2020)

Identification of antigens presented by MHC for vaccines against tuberculosis
Tekijä: Bettencourt, P, et al.
Julkaistu: (2020)

Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics
Tekijä: Purcell, A, et al.
Julkaistu: (2019)

Immunopeptidomics special issue
Tekijä: Ternette, N, et al.
Julkaistu: (2018)

Discrimination between human leukocyte antigen class I-bound and co-purified HIV-derived peptides in immunopeptidomics workflows
Tekijä: Partridge, T, et al.
Julkaistu: (2018)

Implications of MHC-restricted immunopeptidome in transplantation
Tekijä: Zhuldyz Zhanzak, et al.
Julkaistu: (2024-07-01)

Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer identifies potential immunotherapy target antigens
Tekijä: Ternette, N, et al.
Julkaistu: (2018)

Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I
Tekijä: Owen Leddy, et al.
Julkaistu: (2023-04-01)

Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows
Tekijä: Thomas Partridge, et al.
Julkaistu: (2018-04-01)

Solving an MHC allele–specific bias in the reported immunopeptidome
Tekijä: Martin G. Klatt, et al.
Julkaistu: (2020-10-01)

The yin/yang balance of the MHC-self-immunopeptidome
Tekijä: Laura Santambrogio, et al.
Julkaistu: (2022-11-01)

MS-rescue: a computational pipeline to increase the quality and yield of immunopeptidomics experiments
Tekijä: Andreatta, M, et al.
Julkaistu: (2019)

Identification and selection of novel mycobacterial antigens using immunopeptidomics and immunoinformatics for the development of subunit vaccines against tuberculosis
Tekijä: Almujri, SS
Julkaistu: (2022)

Critical Review of Existing MHC I Immunopeptidome Isolation Methods
Tekijä: Alexandr Kuznetsov, et al.
Julkaistu: (2020-11-01)

Molecular Determinants Regulating the Plasticity of the MHC Class II Immunopeptidome
Tekijä: Laura Santambrogio, et al.
Julkaistu: (2022-05-01)

Identification and evaluation of novel protective antigens for the development of a candidate TB subunit vaccine
Tekijä: Stylianou, E, et al.
Julkaistu: (2018)

A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against M.tb challenge
Tekijä: Stylianou, E, et al.
Julkaistu: (2023)

Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues
Tekijä: Peter Kubiniok, et al.
Julkaistu: (2022-02-01)

Escape from the phagosome: the explanation for MHC-I processing of mycobacterial antigens?
Tekijä: Melanie eHarriff, et al.
Julkaistu: (2012-03-01)

The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation
Tekijä: Etienne Caron, et al.
Julkaistu: (2011-09-01)

Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1+ KLRG1− CD4+ T cells
Tekijä: Bull, N, et al.
Julkaistu: (2018)

Variations in MHC class I antigen presentation and immunopeptidome selection pathways [version 1; peer review: 3 approved]
Tekijä: Anita J. Zaitouna, et al.
Julkaistu: (2020-09-01)

Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA)
Tekijä: Tanner, R, et al.
Julkaistu: (2021)

Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model
Tekijä: Pinpathomrat, N, et al.
Julkaistu: (2021)

Accurate MHC Motif Deconvolution of Immunopeptidomics Data Reveals a Significant Contribution of DRB3, 4 and 5 to the Total DR Immunopeptidome
Tekijä: Saghar Kaabinejadian, et al.
Julkaistu: (2022-01-01)

Structural aspects of chemical modifications in the MHC-restricted immunopeptidome; Implications for immune recognition
Tekijä: Tatyana Sandalova, et al.
Julkaistu: (2022-08-01)

Neoantigen characteristics in the context of the complete predicted MHC class I self-immunopeptidome
Tekijä: Scott D. Brown, et al.
Julkaistu: (2019-03-01)

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection
Tekijä: Betts, G, et al.
Julkaistu: (2012)

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection.
Tekijä: Gareth Betts, et al.
Julkaistu: (2012-01-01)

Unlocking the secrets of the immunopeptidome: MHC molecules, ncRNA peptides, and vesicles in immune response
Tekijä: Arpita Balakrishnan, et al.
Julkaistu: (2025-01-01)

Protocol for purification and identification of MHC class I immunopeptidome from cancer cell lines
Tekijä: Sonali V. Mohan, et al.
Julkaistu: (2021-03-01)

Obesity Reshapes Visceral Fat-Derived MHC I Associated-Immunopeptidomes and Generates Antigenic Peptides to Drive CD8+ T Cell Responses
Tekijä: Xiaoling Chen, et al.
Julkaistu: (2020-04-01)

A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against M.tb challenge
Tekijä: Elena Stylianou, et al.
Julkaistu: (2023-10-01)

Thermostability profiling of MHC-bound peptides: a new dimension in immunopeptidomics and aid for immunotherapy design
Tekijä: Emma C. Jappe, et al.
Julkaistu: (2020-12-01)

Evaluation of immune profiles associated with control of mycobacterial growth in systemic lupus erythematosus (SLE) patients
Tekijä: Ongarj, J, et al.
Julkaistu: (2024)

Editorial: Immunopeptidomic Approaches for the Identification of Tumor (neo)Antigens
Tekijä: Jennie R. Lill, et al.
Julkaistu: (2022-05-01)

Immunopeptidomic Analysis of BoLA-I and BoLA-DR Presented Peptides from <i>Theileria parva</i> Infected Cells
Tekijä: Timothy Connelley, et al.
Julkaistu: (2022-11-01)

Hypoxia inhibits MHC I expression and antigen presentation to escape immune surveillance
Tekijä: Estephan, H, et al.
Julkaistu: (2025)

TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification
Tekijä: Naomi Hoenisch Gravel, et al.
Julkaistu: (2023-11-01)

LTR retroelement expansion of the human cancer transcriptome and immunopeptidome revealed by de novo transcript assembly
Tekijä: Attig, J, et al.
Julkaistu: (2019)